May 2020

COVID-19 AND INSURANCE CLAIMS “WHAT YOU NEED TO KNOW”

(May 29, 2020) Governments and health authorities across the United States are responding to the outbreak of COVID-19 through the use of stay-at-home orders and other federal, state, and local orders in an attempt to disrupt the spread of COVID-19. As a result of these measures to disrupt the spread of COVID-19, many businesses have […]

ELMIRON LITIGATION: EMERGING TORTS

By Rachel Shkolnik, Hunter J. Shkolnik Napoli Shkolnik, PLLC (May 27, 2020) The nationwide Elmiron eye damage litigation has picked up headlines over the past several months. Elmiron, the brand name for pentosan polysulfate sodium, is a semi-synthetically produced heparin-like macromolecular carbohydrate derivative.[1]  The lawsuit is centralized around the basis that the drug causes an […]

The Truvada-Atripla Litigation And The Many Layers Involved

“Personal Injury-Patent Infringement COVID-19 Are All In The Mix” Click Here to view the FDA Link to the Truvada Label “Gilead Sciences and their Truvada/Atripla drug line are facing litigation on several fronts including patent infringement claims by the US Dept of Health and Human Services along with the personal injury claims and CDC research […]

U.S. Office of Special Counsel Complaint & Disclosure Form

Rick Bright’s Primary Claims Include:Retaliation for Protected Activity An agency official is prohibited from taking, failing to take, or threatening to take or fail to take a against any employee or applicant for federal employment because of (A) the exercise of an appeal, complaint, or grievance right granted by any law, rule or regulation; (B) […]